1. TRESK channel activation ameliorates migraine-like pain via modulation of CGRP release from the trigeminovascular system and meningeal mast cells in experimental migraine models.
- Author
-
Torun IE, Kilinc YB, Kilinc E, and Töre F
- Subjects
- Animals, Male, Rats, Brain Stem metabolism, Brain Stem drug effects, Capsaicin pharmacology, Hyperalgesia drug therapy, Hyperalgesia metabolism, Nitroglycerin pharmacology, Pain drug therapy, Pain metabolism, Potassium Channels metabolism, Proto-Oncogene Proteins c-fos metabolism, Rats, Sprague-Dawley, Sumatriptan pharmacology, Trigeminal Ganglion metabolism, Trigeminal Ganglion drug effects, Calcitonin Gene-Related Peptide metabolism, Disease Models, Animal, Mast Cells metabolism, Mast Cells drug effects, Meninges metabolism, Meninges drug effects, Meninges blood supply, Migraine Disorders metabolism, Migraine Disorders drug therapy
- Abstract
Aims: Accumulating evidence indicates the involvement of TRESK potassium channels in migraine, however, effects of TRESK activation on migraine-related mechanisms remain unclear. We explored effects of TRESK channel modulation on migraine-related behavioral and molecular markers in in-vivo and ex-vivo rat models of migraine., Main Methods: The selective TRESK activator cloxyquin at different doses, the TRESK inhibitor A2764, and the migraine drug sumatriptan were tested alone or in different combinations in nitroglycerin (NTG)-induced in-vivo model, and in ex-vivo meningeal, trigeminal ganglion and brainstem preparations in which CGRP release was induced by capsaicin. Mechanical allodynia, CGRP and c-fos levels in trigeminovascular structures and meningeal mast cells were evaluated., Key Findings: Cloxyquin attenuated NTG-induced mechanical allodynia, brainstem c-fos and CGRP levels, trigeminal ganglion CGRP levels and meningeal mast cell degranulation and number, in-vivo. It also diminished capsaicin-induced CGRP release from ex-vivo meningeal, trigeminal ganglion and brainstem preparations. Specific TRESK inhibitor A2764 abolished all effects of cloxyquin in in-vivo and ex-vivo. Combining cloxyquin and sumatriptan exerted a synergistic effect ex-vivo, but not in-vivo., Significance: Our findings provide the experimental evidence for the anti-migraine effect of TRESK activation in migraine-like conditions. The modulation of TRESK channels may therefore be an attractive alternative strategy to relieve migraine pain., Competing Interests: Declaration of competing interest The authors declared that they have no potential conflicts of interest., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF